Cai Lei’s ALS Mission: Pushing Forward After Drug Mismatch
Despite a mismatch with the new Rag-17 ALS drug, Cai Lei leads research, funds studies, and trains families, showing resilience and inspiring the ALS community.
Stay informed, stay connected—news for amigos everywhere.
Despite a mismatch with the new Rag-17 ALS drug, Cai Lei leads research, funds studies, and trains families, showing resilience and inspiring the ALS community.